Peritoneal dialysis for eliminating copper in patients with Wilson's disease
Guérin, J.M.; Raux, M.; Meresse, S.; Lamotte, M.
La Semaine des Hopitaux Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(10): 613-615
1982
ISSN/ISBN: 0037-1777 PMID: 6278604 Document Number: 190054
We report a case of Wilson's disease, with a rapidly progressive course, in which peritoneal dialysis was performed. The physiopathology of acute features occurring during the course of the disease is reviewed. The different methods for eliminating copper, particularly peritoneal dialysis, are discussed. The authors recall the precautions which are necessary when initiating D-penicillamine therapy.
Document emailed within 1 workday
Related Documents
Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348Lee, H.H.; Hill, G.M.; Sikha, V.K.; Brewer, G.J.; Prasad, A.S.; Owyang, C. 1990: Pancreaticobiliary secretion of zinc and copper in normal persons and patients with Wilson's disease Journal of Laboratory and Clinical Medicine 116(3): 283-288
Diaz, J.; Acosta, F.; Cañizares, F.; Bueno, F.S.; Tornel, P.L.; Tovar, I.; Contreras, R.F.; Marquez, M.; Martinez, P.; Parrilla, P. 1995: Does orthotopic liver transplantation normalize copper metabolism in patients with Wilson's disease? Transplantation Proceedings 27(4): 2306
Marecek, Z.; Heyrovský, A.; Volek, V. 1975: The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease Acta Hepato-Gastroenterologica 22(5): 292-296
McQuaid, A.; Lamand, M.; Mason, J. 1992: The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy Journal of Laboratory and Clinical Medicine 119(6): 744-750
Yongsiri, S.; Thammakumpee, J.; Prongnamchai, S.; Dinchuthai, P.; Chueansuwan, R.; Tangjaturonrasme, S.; Chaivanit, P. 2014: The association between bioimpedance analysis and quality of life in pre-dialysis stage 5 chronic kidney disease, hemodialysis and peritoneal dialysis patients Journal of the Medical Association of Thailand 97(3): 293-299
Pietrzak, I.; Baczyk, K.; Ksiazek, P. 1995: Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 50: 197-203
Kanjanabuch, T.; Puttipittayathorn, N.; Leelahavanichkul, A.; Lieusuwan, S.; Katavetin, P.; Mahatanan, N.; Sriudom, K.; Chirananthavat, T.; Thongbor, N.; Eiam-Ong, S. 2011: Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients Journal of the Medical Association of Thailand 94(Suppl 4): S119-S125
Oba, I.; Mori, T.; Chida, M.; Kurasawa, N.; Naganuma, E.; Sato, E.; Koizumi, K.; Sato, S.; Tsuchikawa, M.; Ito, S. 2015: Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 31: 11-16
Fourtounas, C.; Savidaki, E.; Roumelioti, M.; Dousdampanis, P.; Hardalias, A.; Kalliakmani, P.; Papachristou, E.; Drakopoulos, A.; Goumenos, D.S.; Vlachojannis, J.G. 2006: Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 187-191
Fein, P.A.; Fazil, I.; Rafiq, M.A.; Schloth, T.; Matza, B.; Chattopadhyay, J.; Avram, M.M. 2006: Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 2-6
Juergensen, P.H.; Murphy, A.L.; Pherson, K.A.; Chorney, W.S.; Kliger, A.S.; Finkelstein, F.O. 1999: Tidal peritoneal dialysis to achieve comfort in chronic peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 15: 125-126
Dastych, M. 1999: Serum levels of zinc, copper and selenium in patients with Wilson's disease treated with zinc Vnitrni Lekarstvi 45(4): 217-219
Yuzbasiyan-Gurkan, V.; Brewer, G.J.; Abrams, G.D.; Main, B.; Giacherio, D. 1989: Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease Journal of Laboratory and Clinical Medicine 114(5): 520-526
Stapelbroek, J.M.; Ploos van Amstel, J.K.; van Hattum, J.; van den Berg, L.H.; Klomp, L.W.J.; Houwen, R.H.J. 2003: From gene to disease; Wilson disease: copper storage due to mutations in ATP7B Nederlands Tijdschrift Voor Geneeskunde 147(13): 603-605
McCoy, K.L.; Goldstein, D.R.; Gahtan, V.; Mayro, G.; Kerstein, M.D. 2001: Peripheral vascular disease intervention in patients with end-stage renal disease: few complications in those treated with peritoneal dialysis Southern Medical Journal 94(10): 1002-1005
Odièvre, M.; Benard, J.M.; Debray, H.; Neveu, Y.; Leleu, C.; Yvart, J.; Labrune, P.; Archambaud, F.; Bedossa, P.; Le Stradic, C. 1988: Wilson's disease with liver copper in normal concentration Archives Francaises de Pediatrie 45(8): 565-567
Armstrong, A.; Cunningham, J. 1994: The treatment of metabolic bone disease in patients on peritoneal dialysis Kidney International. Suppl 48: S51-S57
Wawschinek, O.; Beyer, W. 1982: Determination of copper in liver puncture samples in the diagnosis of Wilson's disease Journal of Clinical Chemistry and Clinical Biochemistry 20(12): 929-930
Huang, T.P.; Lian, J.D.; Ho, L.T. 1986: Continuous ambulatory peritoneal dialysis for the end stage renal disease patients Journal of the Formosan Medical Association 85(11): 1011-1022